Outcomes of single- and two-stage revision total knee arthroplasty for chronic periprosthetic joint infection

医学 假体周围 生存曲线 外科 队列 关节置换术 比例危险模型 内科学 回顾性队列研究 阶段(地层学) 癌症 生物 古生物学
作者
Hosam E. Matar,Benjamin V. Bloch,S. Snape,Peter James
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (8): 1373-1379 被引量:41
标识
DOI:10.1302/0301-620x.103b8.bjj-2021-0224.r1
摘要

Aims Single-stage revision total knee arthroplasty (rTKA) is gaining popularity in treating chronic periprosthetic joint infections (PJIs). We have introduced this approach to our clinical practice and sought to evaluate rates of reinfection and re-revision, along with predictors of failure of both single- and two-stage rTKA for chronic PJI. Methods A retrospective comparative cohort study of all rTKAs for chronic PJI between 1 April 2003 and 31 December 2018 was undertaken using prospective databases. Patients with acute infections were excluded; rTKAs were classified as single-stage, stage 1, or stage 2 of two-stage revision. The primary outcome measure was failure to eradicate or recurrent infection. Variables evaluated for failure by regression analysis included age, BMI, American Society of Anesthesiologists grade, infecting organisms, and the presence of a sinus. Patient survivorship was also compared between the groups. Results A total of 292 consecutive first-time rTKAs for chronic PJI were included: 82 single-stage (28.1%); and 210 two-stage (71.9%) revisions. The mean age was 71 years (27 to 90), with 165 females (57.4%), and a mean BMI of 30.9 kg/m 2 (20 to 53). Significantly more patients with a known infecting organism were in the single-stage group (93.9% vs 80.47%; p = 0.004). The infecting organism was identified preoperatively in 246 cases (84.2%). At a mean follow-up of 6.3 years (2.0 to 17.6), the failure rate was 6.1% in the single-stage, and 12% in the two-stage groups. All failures occurred within four years of treatment. The presence of a sinus was an independent risk factor for failure (odds ratio (OR) 4.97; 95% confidence interval (CI) 1.593 to 15.505; p = 0.006), as well as age > 80 years (OR 5.962; 95% CI 1.156 to 30.73; p = 0.033). The ten-year patient survivorship rate was 72% in the single-stage group compared with 70.5% in the two-stage group. This difference was not significant (p = 0.517). Conclusion Single-stage rTKA is an effective strategy with a high success rate comparable to two-stage approach in appropriately selected patients. Cite this article: Bone Joint J 2021;103-B(8):1373–1379.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
ASDGFJFK完成签到,获得积分10
1秒前
1秒前
哈哈完成签到 ,获得积分10
3秒前
优雅冷菱完成签到,获得积分20
5秒前
二师兄小刘完成签到,获得积分10
5秒前
6秒前
sfdghik完成签到,获得积分10
7秒前
9秒前
11秒前
自信的易云完成签到 ,获得积分10
11秒前
星辰大海应助CJH采纳,获得10
11秒前
锦慜完成签到 ,获得积分10
12秒前
XuBo完成签到,获得积分20
14秒前
细腻听白发布了新的文献求助100
14秒前
pluto应助诗谙采纳,获得10
15秒前
张翊心发布了新的文献求助10
15秒前
鲸落发布了新的文献求助10
15秒前
jjjcy发布了新的文献求助10
17秒前
想人陪的远锋完成签到,获得积分10
17秒前
lzq671发布了新的文献求助10
17秒前
豆豆的姐姐完成签到 ,获得积分10
18秒前
18秒前
18秒前
英吉利25发布了新的文献求助10
22秒前
CHANYEOL完成签到 ,获得积分10
22秒前
鱼可完成签到 ,获得积分10
22秒前
烟花应助蓝天采纳,获得10
23秒前
搜集达人应助咻咻采纳,获得10
23秒前
科研通AI6.2应助张KT采纳,获得10
25秒前
烂漫起眸完成签到,获得积分10
25秒前
晨晨尼完成签到,获得积分10
27秒前
29秒前
30秒前
MelonSeed应助累啊采纳,获得10
30秒前
30秒前
33秒前
樊焕焕完成签到,获得积分20
34秒前
科研通AI6.4应助jjjcy采纳,获得10
34秒前
小马甲应助晓晓鹤采纳,获得10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Wiley Blackwell Companion to Diachronic and Historical Linguistics 3000
The impact of workplace variables on juvenile probation officers’ job satisfaction 1000
When the badge of honor holds no meaning anymore 1000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6282141
求助须知:如何正确求助?哪些是违规求助? 8100972
关于积分的说明 16938034
捐赠科研通 5349144
什么是DOI,文献DOI怎么找? 2843367
邀请新用户注册赠送积分活动 1820558
关于科研通互助平台的介绍 1677469